Publications

Detailed Information

New developments in our understanding of acne pathogenesis and treatment

DC Field Value Language
dc.contributor.authorKurokawa, Ichiro-
dc.contributor.authorDanby, F. William-
dc.contributor.authorJu, Qiang-
dc.contributor.authorWang, Xiuli-
dc.contributor.authorXia, Longqing-
dc.contributor.authorNagy, Istvan-
dc.contributor.authorSuh, Dae Hun-
dc.contributor.authorSchagen, Silke-
dc.contributor.authorZouboulis, Christos C.-
dc.contributor.authorTsatsou, Fragkiski-
dc.contributor.authorGanceviciene, Ruta-
dc.contributor.authorPicardo, Mauro-
dc.contributor.authorChen, WenChieh-
dc.contributor.authorXiang, Leihong Flora-
dc.date.accessioned2012-07-04T04:16:16Z-
dc.date.available2012-07-04T04:16:16Z-
dc.date.issued2009-10-
dc.identifier.citationEXPERIMENTAL DERMATOLOGY; Vol.18(10); 821-832ko_KR
dc.identifier.issn0906-6705-
dc.identifier.urihttps://hdl.handle.net/10371/78390-
dc.description.abstractInterest in sebaceous gland physiology and its diseases is rapidly increasing. We provide a summarized update of the current knowledge of the pathobiology of acne vulgaris and new treatment concepts that have emerged in the last 3 years (2005-2008). We have tried to answer questions arising from the exploration of sebaceous gland biology, hormonal factors, hyperkeratinization, role of bacteria, sebum, nutrition, cytokines and toll-like receptors (TLRs). Sebaceous glands play an important role as active participants in the innate immunity of the skin. They produce neuropeptides, excrete antimicrobial peptides and exhibit characteristics of stem cells. Androgens affect sebocytes and infundibular keratinocytes in a complex manner influencing cellular differentiation, proliferation, lipogenesis and comedogenesis. Retention hyperkeratosis in closed comedones and inflammatory papules is attributable to a disorder of terminal keratinocyte differentiation. Propionibacterium acnes, by acting on TLR-2, may stimulate the secretion of cytokines, such as interleukin (IL)-6 and IL-8 by follicular keratinocytes and IL-8 and -12 in macrophages, giving rise to inflammation. Certain P. acnes species may induce an immunological reaction by stimulating the production of sebocyte and keratinocyte antimicrobial peptides, which play an important role in the innate immunity of the follicle. Qualitative changes of sebum lipids induce alteration of keratinocyte differentiation and induce IL-1 secretion, contributing to the development of follicular hyperkeratosis. High glycemic load food and milk may induce increased tissue levels of 5 alpha-dihydrotestosterone. These new aspects of acne pathogenesis lead to the considerations of possible customized therapeutic regimens. Current research is expected to lead to innovative treatments in the near future.ko_KR
dc.language.isoenko_KR
dc.publisherWILEY-BLACKWELL PUBLISHING, INCko_KR
dc.subjectsebaceous glandko_KR
dc.subjectToll-like receptorko_KR
dc.subjecthyperkeratinizationko_KR
dc.subjectPPARko_KR
dc.subjectcytokineko_KR
dc.subjectacneko_KR
dc.titleNew developments in our understanding of acne pathogenesis and treatmentko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor서대헌-
dc.identifier.doi10.1111/j.1600-0625.2009.00890.x-
dc.citation.journaltitleEXPERIMENTAL DERMATOLOGY-
dc.description.citedreferenceZouboulis CC, 2008, EXP GERONTOL, V43, P986, DOI 10.1016/j.exger.2008.09.001-
dc.description.citedreferenceNakatsuji T, 2008, J INVEST DERMATOL, V128, P2451, DOI 10.1038/jid.2008.117-
dc.description.citedreferenceMelnik B, 2008, J DTSCH DERMATOL GES, V6, P721, DOI 10.1111/j.1610-0387.2008.06822.x-
dc.description.citedreferencePalomba S, 2008, CURR OPIN OBSTET GYN, V20, P364-
dc.description.citedreferenceLee DY, 2008, J INVEST DERMATOL, V128, P1863, DOI 10.1038/sj.jid.5701235-
dc.description.citedreferenceZouboulis CC, 2008, EXP DERMATOL, V17, P542, DOI 10.1111/j.1600-0625.2008.00725.x-
dc.description.citedreferenceDel Rosso JQ, 2008, J DRUGS DERMATOL, V7, pS2-
dc.description.citedreferenceMelnik BC, 2008, BRIT J DERMATOL, V158, P1397, DOI 10.1111/j.1365-2133.2008.08559.x-
dc.description.citedreferenceHong I, 2008, J INVEST DERMATOL, V128, P1266, DOI 10.1038/sj.jid.5701134-
dc.description.citedreferenceLo Celso C, 2008, STEM CELLS, V26, P1241, DOI 10.1634/stemcells.2007-0651-
dc.description.citedreferencePelle E, 2008, J INVEST DERMATOL, V128, P1280, DOI 10.1038/sj.jid.5701160-
dc.description.citedreferenceFuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908-
dc.description.citedreferenceKoltun W, 2008, CONTRACEPTION, V77, P249, DOI 10.1016/j.contraception.2007.11.003-
dc.description.citedreferenceSmith RN, 2008, J DERMATOL SCI, V50, P41, DOI 10.1016/j.jdermsci.2007.11.005-
dc.description.citedreferenceFenner JA, 2008, PEDIATR DERMATOL, V25, P179, DOI 10.1111/j.1525-1470.2008.00628.x-
dc.description.citedreferenceTreloar V, 2008, J AM ACAD DERMATOL, V58, P175, DOI 10.1016/j.jaad.2007.10.017-
dc.description.citedreferenceGANCEVICIENE R, 2008, BRIT J DERMATOL, V160, P345-
dc.description.citedreferenceDanby FW, 2008, CLIN DERMATOL, V26, P93, DOI 10.1016/j.clindermatol.2007.09.018-
dc.description.citedreferenceJarrousse V, 2007, ARCH DERMATOL RES, V299, P441, DOI 10.1007/s00403-007-0774-5-
dc.description.citedreferenceRussell LE, 2007, EXP DERMATOL, V16, P844, DOI 10.1111/j.1600-0625.2007.00612.x-
dc.description.citedreferenceCharakida A, 2007, BRIT J DERMATOL, V157, P569, DOI 10.1111/j.1365-2133.2007.08083.x-
dc.description.citedreferenceKurokawa I, 2007, BRIT J DERMATOL, V157, P415, DOI 10.1111/j.1365-2133.2007.08047.x-
dc.description.citedreferenceVerfaille CJ, 2007, BRIT J DERMATOL, V157, P122, DOI 10.1111/j.1365-2133.2007.07896.x-
dc.description.citedreferenceGanceviciene R, 2007, EXP DERMATOL, V16, P547, DOI 10.1111/j.1600-0625.2007.00565.x-
dc.description.citedreferenceHarrison WJ, 2007, J INVEST DERMATOL, V127, P1309, DOI 10.1038/sj.jid.5700743-
dc.description.citedreferenceHana A, 2007, LIFE SCI, V80, P2214, DOI 10.1016/j.lfs.2007.02.007-
dc.description.citedreferenceThielitz A, 2007, J INVEST DERMATOL, V127, P1042, DOI 10.1038/sj.jid.5700439-
dc.description.citedreferenceStecova J, 2007, PHARM RES, V24, P991, DOI 10.1007/s11095-006-9225-9-
dc.description.citedreferenceClarke SB, 2007, DERMATOL CLIN, V25, P137, DOI 10.1016/j.det.2007.01.004-
dc.description.citedreferenceKurokawa I, 2007, J CUTAN PATHOL, V34, P338, DOI 10.1111/j.1600-0560.2006.00619.x-
dc.description.citedreferenceMakrantonaki E, 2007, BRIT J DERMATOL, V156, P428, DOI 10.1111/j.1365-2133.2006.07671.x-
dc.description.citedreferenceZiegler CG, 2007, HORM METAB RES, V39, P106, DOI 10.1055/s-2007-961809-
dc.description.citedreferenceKrause K, 2007, HORM METAB RES, V39, P166, DOI 10.1055/s-2007-961811-
dc.description.citedreferenceSeiffert K, 2007, HORM METAB RES, V39, P141, DOI 10.1055/s-2007-961814-
dc.description.citedreferenceFimmel S, 2007, HORM METAB RES, V39, P149, DOI 10.1055/s-2007-961815-
dc.description.citedreferenceLUCKY AW, 2007, J DRUGS DERMATOL, V6, P981-
dc.description.citedreferenceDanby FW, 2007, J AM ACAD DERMATOL, V56, P164, DOI 10.1016/j.jaad.2006.04.022-
dc.description.citedreferenceOttaviani M, 2006, J INVEST DERMATOL, V126, P2430, DOI 10.1038/sj.jid.5700434-
dc.description.citedreferenceChen WC, 2006, J INVEST DERMATOL, V126, P2332, DOI 10.1038/sj.jid.5700442-
dc.description.citedreferenceGan L, 2006, IMMUNOL RES, V35, P295, DOI 10.1385/IR:35:3:295-
dc.description.citedreferenceTrivedi NR, 2006, J INVEST DERMATOL, V126, P2002, DOI 10.1038/sj.jid.5700336-
dc.description.citedreferenceGrando SA, 2006, J INVEST DERMATOL, V126, P1948, DOI 10.1038/sj.jid.5700151-
dc.description.citedreferenceLayton AM, 2006, J EUR ACAD DERMATOL, V20, P773, DOI 10.1111/j.1468-3083.2006.01671.x-
dc.description.citedreferenceNagy I, 2006, MICROBES INFECT, V8, P2195, DOI 10.1016/j.micinf.2006.04.001-
dc.description.citedreferencePasquali R, 2006, EUR J ENDOCRINOL, V154, P763, DOI 10.1530/eje.1.02156-
dc.description.citedreferenceSuzuki N, 2006, SCIENCE, V311, P1927, DOI 10.1126/science.1124256-
dc.description.citedreferenceSchroder JM, 2006, CELL MOL LIFE SCI, V63, P469, DOI 10.1007/s00018-005-5364-0-
dc.description.citedreferenceZhang L, 2006, PEPTIDES, V27, P413, DOI 10.1016/j.peptides.2005.05.030-
dc.description.citedreferenceAlestas T, 2006, J MOL MED-JMM, V84, P75, DOI 10.1007/s00109-005-0715-8-
dc.description.citedreferenceMELO MN, 2006, RECENT PAT ANTIINFEC, V1, P201-
dc.description.citedreferenceOeff MK, 2006, DERMATOLOGY, V213, P266, DOI 10.1159/000095056-
dc.description.citedreferenceMITKOV M, 2006, EUR J OBSTET GYN R B, V126, P93-
dc.description.citedreferenceGanceviciene R, 2006, DERMATOLOGY, V213, P270, DOI 10.1159/000095058-
dc.description.citedreferenceIRAJI F, 2006, DERMATOL ONLINE J, V12, P26-
dc.description.citedreferenceYoun SW, 2005, BRIT J DERMATOL, V153, P919, DOI 10.1111/j.1365-2133.2005.06794.x-
dc.description.citedreferencePapakonstantinou E, 2005, J INVEST DERMATOL, V125, P673, DOI 10.1111/j.0022-202X.2005.23848.x-
dc.description.citedreferenceOhnuma K, 2005, MOL CELL BIOL, V25, P7743, DOI 10.1128/MCB.25.17.7743-7757.2005-
dc.description.citedreferenceGeorgel P, 2005, INFECT IMMUN, V73, P4512, DOI 10.1128/IAI.73.8.4512-4521.2005-
dc.description.citedreferenceNagy I, 2005, J INVEST DERMATOL, V124, P931, DOI 10.1111/j.0022-202X.2005.23705.x-
dc.description.citedreferenceHoyt G, 2005, BRIT J NUTR, V93, P175, DOI 10.1079/BJN20041304-
dc.description.citedreferenceAdebamowo CA, 2005, J AM ACAD DERMATOL, V52, P207, DOI 10.1016/j.jaad.2004.08.007-
dc.description.citedreferenceMcDowell A, 2005, J CLIN MICROBIOL, V43, P326, DOI 10.1128/JCM.43.1.326-334.2005-
dc.description.citedreferenceKurzen H, 2004, J INVEST DERMATOL, V123, P937, DOI 10.1111/j.0022-202X.2004.23425.x-
dc.description.citedreferenceZouboulis CC, 2004, CLIN DERMATOL, V22, P360, DOI 10.1016/j.clindermatol.2004.03.004-
dc.description.citedreferenceNamazi MR, 2004, INT J DERMATOL, V43, P701-
dc.description.citedreferenceSmolinski KN, 2004, CURR OPIN PEDIATR, V16, P385-
dc.description.citedreferenceBruggemann H, 2004, SCIENCE, V305, P671-
dc.description.citedreferenceReinel D, 2004, HAUTARZT, V55, P143, DOI 10.1007/s00105-003-0680-5-
dc.description.citedreferenceBALANA ME, 2004, J DRUGS DERMATOL, V3, P287-
dc.description.citedreferenceBurkhart CN, 2003, INT J DERMATOL, V42, P925-
dc.description.citedreferenceNiemann C, 2003, P NATL ACAD SCI USA, V100, P11873, DOI 10.1073/pnas.1834202100-
dc.description.citedreferenceChen WC, 2003, J INVEST DERMATOL, V121, P441-
dc.description.citedreferenceRosignoli C, 2003, EXP DERMATOL, V12, P480-
dc.description.citedreferenceAnsorge S, 2003, Z NATURFORSCH C, V58, P580-
dc.description.citedreferenceThiboutot D, 2003, J INVEST DERMATOL, V120, P905-
dc.description.citedreferenceZhang L, 2003, ANN NY ACAD SCI, V994, P154-
dc.description.citedreferenceKoreck A, 2003, DERMATOLOGY, V206, P96, DOI 10.1159/000068476-
dc.description.citedreferenceJain A, 2003, PHYTOMEDICINE, V10, P34, DOI 10.1078/094471103321648638-
dc.description.citedreferenceMilani M, 2003, CURR MED RES OPIN, V19, P135, DOI 10.1185/030079903125001523-
dc.description.citedreferenceHuang QH, 2002, NEUROSCI LETT, V334, P186-
dc.description.citedreferenceToyoda M, 2002, EUR J DERMATOL, V12, P422-
dc.description.citedreferenceKim J, 2002, J IMMUNOL, V169, P1535-
dc.description.citedreferenceToyoda M, 2002, EXP DERMATOL, V11, P241-
dc.description.citedreferenceZouboulis CC, 2002, P NATL ACAD SCI USA, V99, P7148, DOI 10.1073/pnas.102180999-
dc.description.citedreferenceBohm M, 2002, J INVEST DERMATOL, V118, P533-
dc.description.citedreferenceNakamura M, 2001, EXP DERMATOL, V10, P369-
dc.description.citedreferenceChronnell CMT, 2001, J INVEST DERMATOL, V117, P1120-
dc.description.citedreferenceSato T, 2001, J INVEST DERMATOL, V117, P965-
dc.description.citedreferenceKono M, 2001, FASEB J, V15, P2297-
dc.description.citedreferenceFreedberg IM, 2001, J INVEST DERMATOL, V116, P633-
dc.description.citedreferenceLomri A, 2001, J BONE MINER RES, V16, P705-
dc.description.citedreferenceGhazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215-
dc.description.citedreferenceZouboulis CC, 2001, DERMATOLOGY, V203, P277-
dc.description.citedreferenceThiboutot D, 2000, J INVEST DERMATOL, V115, P614-
dc.description.citedreferenceTaylor G, 2000, CELL, V102, P451-
dc.description.citedreferenceDeplewski D, 2000, ENDOCR REV, V21, P363-
dc.description.citedreferenceZouboulis CC, 1999, J INVEST DERMATOL, V113, P1011-
dc.description.citedreferenceMunro CS, 1998, LANCET, V352, P704-
dc.description.citedreferenceScholzen T, 1998, EXP DERMATOL, V7, P81-
dc.description.citedreferenceZouboulis CC, 1998, DERMATOLOGY, V196, P21-
dc.description.citedreferenceThiboutot DM, 1997, BRIT J DERMATOL, V136, P166-
dc.description.citedreferenceBernerd F, 1996, ARCH DERMATOL RES, V288, P586-
dc.description.citedreferenceGuy R, 1996, J INVEST DERMATOL, V106, P454-
dc.description.citedreferenceHughes BR, 1996, BRIT J DERMATOL, V134, P247-
dc.description.citedreferenceKOLDOVSKY O, 1995, VITAM HORM, V50, P77-
dc.description.citedreferenceZOUBOULIS CC, 1994, EXP DERMATOL, V3, P151-
dc.description.citedreferenceAKAMATSU H, 1992, J INVEST DERMATOL, V99, P509-
dc.description.citedreferencePASSI S, 1991, J DERMATOL SCI, V2, P84-
dc.description.citedreferenceZOUBOULIS CC, 1991, SKIN PHARMACOL, V4, P74-
dc.description.citedreferenceXIA LQ, 1989, J INVEST DERMATOL, V93, P315-
dc.description.citedreferenceTHODY AJ, 1989, PHYSIOL REV, V69, P383-
dc.description.citedreferenceKUROKAWA I, 1988, J INVEST DERMATOL, V91, P566-
dc.description.citedreferenceDOWNING DT, 1986, J AM ACAD DERMATOL, V14, P221-
dc.description.citedreferenceDARLING JAB, 1974, J ENDOCRINOL, V62, P291-
dc.description.citedreferenceKNUTSON DD, 1974, J INVEST DERMATOL, V62, P288-
dc.description.citedreferenceKLIGMAN AM, 1970, ARCH DERMATOL, V102, P267-
dc.description.tc54-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share